Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Joseph Harvey

As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Candioli to expand global reach of new UK acquisition

Italian companion animal health company Candioli aims to grow the European horizons of its latest acquisition.

Deals M&A

Schein prolongs creation date for Covetrus

Henry Schein has moved the date Covetrus will be created forward, due to the ongoing US government shutdown. 
Operations Henry Schein

US start-up receives investment for gene editing canine cancer treatment

Iowa-based LifEngine Animal Health Laboratories (LEAH) has received a seed investment to support development of canine B cell lymphoma treatment. 

Canine Investments

Stabilized Patterson 'turning the corner' before 2020 acceleration

US distributor Patterson Companies is making "steady progress", according to the firm's president and chief executive Mark Walchirk.

Patterson Companies

Elanco is building 'fit-for-purpose animal health company'

Elanco will spend 2019 and 2020 furthering its productivity plans, as it moves into its next era.

Conference Reports Elanco

New disease set to hit south east Asian shrimp

A new report has highlighted the risk shrimp hemocyte iridescent virus (SHIV) poses to Asia's aquaculture industry.

Aquaculture Asia Pacific
See All